Cite
HARVARD Citation
Peen, U. et al. (n.d.). 388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients. International journal of gynecological cancer. pp. A90-A91. [Online].